{
  "documents": [
    "nutrients Article Nutritional Predictors of Mortality after 10 Years of Follow-Up in Patients with Chronic Kidney Disease at a Multidisciplinary Unit of Advanced Chronic Kidney Disease GuillerminaBarril1, , AngelNogueira1, GracielaAlvarez-García1, AlmudenaNúñez1, CarmenSánchez-González1andMarRuperto2 1 AdvancedChronicKidneyDiseaseUnit, DepartmentofNephrology, HospitalUniversitariodelaPrincesa, C/DiegodeLeón62, 28006Madrid, Spain 2 DepartmentofPharmaceuticalHealthSciences, SchoolofPharmacy, UniversidadSanPablo-CEU, CEU Universities, UrbanizaciónMonteprincipe, 28660Madrid, Spain Correspondence: gbarril43gmail. com Abstract: Nutritionalmonitoringinadvancedchronickidneydisease(ACKD)unitsprovidespersonalizedcareandimprovesclinicaloutcomes. Thisstudyaimedtoidentifymortalityriskfactors inchronickidneydisease(chronic kidney disease)patientsonnutritionalfollow-upinthemultidisciplinaryACKD unit. Aretrospectivecross-sectionalobservationalstudywasconductedin307CKDpatientsstage 3b, 45followed-upfor10years. Clinicalandnutritionalmonitoringwasperformedbymalnutritioninflammationscore(MIS), biochemicalparameters(s-albumin, s-prealbumin, andserumC-reactive Protein(s-CRP), bodycompositionmeasuredbybioelectricalimpedanceanalysis(BIA), anthropometry, andhandgripstrengthmeasurements. Thesamplewasclassifiedintonon-survivors, survivors, Citation: Barril, G. ; Nogueira, A. ; andcensoredgroups. Ofthe307CKDpatients, theprevalenceofprotein-energywasting(protein-energy wasting)was Alvarez-García, G. ; Núñez, A. ; 27. 0%usingMIS5points, s-CRP1mg/dLwas19. 20%, and27. 18%died. Survivorshadhigher Sánchez-González, C. ; Ruperto, M. significantbodycellmass(BCM%)andphaseangle(PA). Survivalanalysessignificantlyshowedthat NutritionalPredictorsofMortality age72years, MIS5points, s-prealbumin≤30mg/dL, PA≤4, andgender-adjustedhandgrip after10YearsofFollow-Upin strength(HGS)wereassociatedwithanincreasedriskofmortality. Byunivariateandmultivariate PatientswithChronicKidney DiseaseataMultidisciplinaryUnitof Coxregression, timeonfollow-up(heart rate: 0. 97), s-prealbumin(heart rate: 0. 94), andrighthandgripstrength AdvancedChronicKidneyDisease. (heart rate: 0. 96)wereindependentpredictorsofmortalityriskat10yearsoffollow-upintheACKDunit. Nutrients2022, 14, 3848. https: // Nutritionalmonitoringinpatientswithstage3b, 45CKDhelpstoidentifyandtreatnutritionalrisk doi. org/10. 3390/nu14183848 earlyandimproveadversemortalityprognosis. AcademicEditor: Yoshiyuki Keywords: ACKD unit; advanced chronic Kidney disease unit; bioelectric impedance analysis; Morishita bodycomposition; chronickidneydisease; fluidoverload; handgripstrength; nutritionalfollow-up; Received: 10August2022 mortality; Protein-energywasting Accepted: 14September2022 Published: 17September2022 PublishersNote: MDPIstaysneutral withregardtojurisdictionalclaimsin 1. Introduction publishedmapsandinstitutionalaffilChronickidneydisease(chronic kidney disease)isestimatedtorisefromthe16thmostcommoncause iations. ofdeathin2016tothe5thin20401, thusincreasingtheprevalenceofCKDexponentially over the coming decades 2. chronic kidney disease has been recognized as an important risk factor for cardiovascular(CV)mortalityandisariskmultiplierinahighpercentageofpatientswith hypertensionanddiabetesmellitus(diabetes mellitus)2. Copyright: 2022 by the authors. Managementofmodifiableriskfactorsassociatedwithfatalandnon-fatalcardiovasLicensee MDPI, Basel, Switzerland. cular events (hypertension, dyslipidemia, poor glycemic control, obesity, and elevated This article is an open access article proteinuria)showedagreaterassociationwithCKDprogressionandmortalityoutcomes, distributed under the terms and whiletheiridentificationandcorrectioneffectivelyimprovedclinicaloutcomes3, 4. conditionsoftheCreativeCommons Oneofthewell-knownCKDprogressionfactorsandindependentpredictorsofmorAttribution(CCBY)license(https: // creativecommons. org/licenses/by/ talityisprotein-energywastingsyndrome(protein-energy wasting), whichcanbehigherthan50. 0%instage 4. 0/). 5CKDbeforestartingrenalreplacementtherapy(RRT)5. PEWisfrequentlyassociated Nutrients2022, 14, 3848. Nutrients2022, 14, 3848 2of15 withfluidoverloadattheexpenseofincreasedextracellularwater(ECW), whetheraccompaniedornotbyexcesstotalbodywater(TBW)whenmusclemass(MM)hasdecreasedin relationtotheinflammatorystate. ThediagnosticcriteriaforPEWweredescribedbythe InternationalSocietyofRenalNutritionandMetabolismin20086, definingmalnutrition inCKDasmorethaninsufficientfoodintakebutalsoassociatedwithinflammation, both feedingbackoneachotherandconstitutingPEWsyndromewhich, amongotheralterations, leadstoadecreaseinbodycompartmentsoffatandfat-freemass(FFM), includingMM5. ThediagnosisofPEWisbasedonseveralcategoriesinwhichbiochemicalparameterssuch asserumalbumin(s-albumin)andserumprealbumin(s-prealbumin), bodymassindex (body mass index), MM, andproteinintakearemodifiedinthepresenceofaninflammationstate. As chronic kidney disease progresses, accumulated uremic toxins, endocrine disturbances such as insulinresistance, metabolicacidosis, andinflammatoryphenomenaleadtoanorexiaand inadequate dietary intake, and increased energy expenditure, which is associated with changesinbodycomposition7. Eachoftheseuremicalterations, separatelyortogether, leadstoincreasedmorbidityandmortalityinCKDpatients. Todate, thereisnosingle markertodefinePEW, andthereforeitisrequiredtouseseveraltoolstoassessnutritional status, combininglaboratoryparameters, bodycomposition, andmusclestrengthmeasures, aswellasvalidatedandrecommendednutritionalscreeningtoolssuchasthemalnutritioninflammationscore(MIS)questionnaire810. Serumalbumin(s-albumin)concentrationasauniversalnutritionalmarkerhasshown thatlevelsbelow3. 8g/dLwereprogressivelyassociatedwithanincreasedmortalityratein CKDpatients11, 12. s-Prealbuminhasbeenconsideredasamarkerasashort-livemarker insomepublishedarticlesaswellasamortalitypredictor13, 14. Furthermore, several studieshaveshownthats-CRPvaluesinkidneypatients1mg/dLor3mg/dLwere associatedwithlowersurvival1517. Bioelectricalimpedanceanalysis(BIA)isavalidatedandsimple-to-performmethod formeasuringbodycompositionandchangesinhydrationstatusinCKDandRRT. Oneof themainfactorsinfluencingoutcomesisphaseangle(PA), whichhasbeenestablishedata cut-offpointof4 indifferentresearchstudies18, 19asapredictorofmortalityinCKD anddialysispatients. Sarcopeniaisacommonconditioncharacterizedbythereductioninskeletalmuscle strength and Low amount muscle quantity or quality. Muscle strength is often more important in chronic kidney disease patients than the amount of MM, because of which there may be a normalamountofmusclebutwithanalteredfiberstructureandlowstrength. Indeed, skeletalmusclestrengthhasalsobeenshowntobethefirstlinktobeconsideredinthe diagnosisofsarcopeniaaccordingtothe2019Europeanconsensus20. Invariousstudies onCKDpatients, theprevalenceofsarcopeniarangesfrom5. 0%to37. 0%dependingon thecriteriausedfordiagnosis2123. InolderCKDpatients, regularphysicalexercise priortoCKDorbeingphysicallyactiveadaptedtothecharacteristicsoftheCKDhelpsto preventand/orimprovemultifactorialsarcopenia24. Therefore, itseemsimportantto recognizenutritionalriskfactorsinthedevelopmentofCKDinordertoemphasizethose markersthatcouldbepredictiveofmortalitybeforestartingRRT. Theaimofthisstudy wastoidentifynutritionalpredictorsofmortalityriskinnon-dialysispatientswithstage 3b-5CKDfollowedfor10yearsinamultidisciplinaryadvancedchronickidneydisease unit(ACKDunit). 2. MaterialsandMethods 2. 1. PatientPopulation Aretrospectivecross-sectionalobservationalstudywascarriedoutinthemultidisciplinaryACKDunitoftheHospitalUniversitarioLaPrincesa(Madrid, Spain)fromFebruary 2012toFebruary2022. Patientsolderthan18yearswereeligibleiftheyhadanestimatedglomerularfiltration rate (estimated glomerular filtration rate) ≤ 45 milliliters per minute/1. 73 m2 or chronic kidney disease stage 3b-5 not on Dialysis 1 and were in theACKDunitformorethan3monthsoffollow-upbeforebeingincludedinthestudy. Nutrients 2022, 14, x FOR PEER REVIEW 3 of 15 2. Materials and Methods 2. 1. Patient Population A retrospective cross-sectional observational study was carried out in the multidisciplinary ACKD unit of the Hospital Universitario La Princesa (Madrid, Spain) from February 2012 to February 2022. Nutrients2022, 14, 3848 3of15 Patients older than 18 years were eligible if they had an estimated glomerular filtration rate (estimated glomerular filtration rate) ≤ 45 milliliters per minute/1. 73 m2 or chronic kidney disease stage 3b-5 not on Dialysis 1 and were in the ACKD unit for more than 3 months of follow-up before being included in the study. ExclusioncriteriawereCKDpatientswithacuteprocesses(e. g. , activeinfection), major Exclusion criteria were chronic kidney disease patients with acute processes (e. g. , active infection), major surgeryinthelast3months, lowerlimbamputation, malignanttumor, nutritionalsupport surgery in the last 3 months, lower limb amputation, malignant tumor, nutritional support withenteraltubefeedingorparenteralnutritionaswellaslifeexpectancy3monthsdue with enteral tube feeding or parenteral nutrition as well as life expectancy 3 months due toanyothercause. to any other cause.",
    "to any other cause. ThecauseofdeathwascategorizedbasedontheInternationalClassificationofDisThe cause of death was categorized based on the International Classification of Diseases10thedition(ICD-10)inthefollowingareas: infectiousdiseases(includingsepsis), eases 10th edition (ICD-10) in the following areas: infectious diseases (including sepsis), cardiovasculardiseases(cardiovascular disease), systemicdiseases(includingdiabetes, lupus, andrheumacardiovascular diseases (cardiovascular disease), systemic diseases (including Diabetes, lupus, and rheumatoidarthritis), gastrointestinaldiseases(includinggastrointestinalbleeding), neurologic toid arthritis), gastrointestinal diseases (including gastrointestinal bleeding), neurologic diseases (including stroke), musculoskeletal diseases, and other causes. Mortality data diseases (including stroke), musculoskeletal diseases, and other causes. Mortality data wereretrospectivelyverifiedfrommedicalrecords. were retrospectively verified from medical records. Atbaseline, 317CKDpatientswereselectedforthisstudy, ofwhich10patientsdid At baseline, 317 chronic kidney disease patients were selected for this study, of which 10 patients did notmeettheinclusioncriteria. Patientswereclassifiedintothreegroups: survivors, no not meet the inclusion criteria. Patients were classified into three groups: survivors, no survivors, andcensoredCKDpatients. Thecausesofcensureamongtheparticipantswere survivors, and censored chronic kidney disease patients. The causes of censure among the participants were theonsetofRRT(hemodialysisorperitonealdialysis), renaltransplantation, ortransferto the onset of RRT (hemodialysis or peritoneal Dialysis), renal transplantation, or transfer anothercenterforotherreasons. Afinalsamplesizeof307ACKDpatientswasincludedin to another center for other reasons. A final sample size of 307 ACKD patients was included thisstudy(Figure1). in this study (Figure 1). n317 eligible chronic kidney disease patients in the ACKD unit 10 patients didnotfulfilltheinclusion criteria -4 patients with incomplete data -3 patientswere only 1 month in the ACKD unit -2 patients with major surgical procedures last month -1 patient with active cancer n307 selected chronic kidney disease patients No Survivor Group SurvivorGroup Censored Group n161 chronic kidney disease patients n61 chronic kidney disease patients n84 chronic kidney disease patients 79 patients started on Dialysis 5 patients were lost in follow-up FiFgiugurere1. 1. F Flolowwchchaartrto offt htheer reeccrruuitimtmeenntta anndds seelleeccttiioonn ooff cchhrroonniicc kkiiddnneeyy ddiisseeaassee ppaattiieennttss iinn tthhee ssttuuddyy. . AACCKKDDu nuinti, ta, dadvavnancecdedc hchrornonicick kididnneyeyd disiesaesaeseu unniti; t; C CKKDD, , c hchroronnicick kididnneeyyd disieseaasese. . This study was conducted by the Helsinki Declaration and Good Clinical Practice Guidelines. Ethicalapprovalandpermissiontoconductthisstudywereobtainedfromthe localEthicsCommittee(codeno: 4257). 2. 2. DataCollection Socio-demographic parameters and clinical, nutritional, and laboratory data were retrospectivelycollectedfromeachpatientsmedicalrecord. ThemainetiologyofCKD andtimeintheACKDunit(months)wererecorded. Theestimatedglomerularfiltration rate(e-glomerular filtration rate)wasmeasuredusingtheChronicKidneyDiseaseEpidemiologyCollaboration (chronic kidney disease-EPI) equation 25. In the ACKD Unit, a comprehensive and multifactorial Nutrients2022, 14, 3848 4of15 approachtothepatientsriskfactorsforprogressionistakenateachmedicalvisit, includingmodifiableriskfactorsforCKDprogression(controlofproteinuria, uricacid), aswell asCVriskfactors(diabetes mellitus, hypertension, dyslipidemia), controlofanemiaandbonemineral metabolism, andunderlyingcomorbidities. Inaddition, asanintegralcomponentofthe careandtreatmentofCKDpatients, nutritionalstatusisusuallyassessedevery3months in conjunction with scheduled medical care. A diet with a Protein intake of 0. 8 g/kg bodyweight/dayanddietarycontrolofsalt, phosphorus, andpotassiumaccordingtothe dietaryguidelinesforpatientswithCKDisusuallyrecommendedthroughpersonalized nutritionalcounselingintheACKDunit11. Adherencetodietaryrecommendations(a dietlowinprotein, saturatedfat, andsalt, aswellaslowinpotassiumandphosphorus andphosphorous/proteinratio)isroutinelymonitoredinallpatientsateachmedicalvisit bye-glomerular filtration rate, proteinuria, andglycosylatedhemoglobinindiabeticpatients, aswellasblood pressuremeasurementsandassessmentofserumsodiumandpotassiumlevels. Dyslipidaemiaisalsoassessedbylipoproteinprofileandmarkerssuchasuricacidaspotentially modifiableCVriskfactorsinadherencetodietarytreatmentinCKDpatients. Likewise, CVriskfactorsaretreatedpharmacologicallybyindividualizedmedicalprescriptionof antihypertensivedrugs, diuretics, lipid-loweringagents, antiplateletagents, ororalanticoagulants. Indiabeticpatients, treatmentwithoralantidiabeticagentsand/orinsulinis prescribedaccordinglytoe-glomerular filtration rate, proteinuria, andserumpotassiumlevelsascomponents ofthecomprehensiveapproachandmultifactorialinterventionintheACKDunit. Normalizedproteinnitrogenappearance(nPna)asasurrogateindicatorofdietary proteinintakeaccordingtotheequationproposedbytheKidneyDiseaseOutcomesQuality Initiativeclinicalpracticeguidelineswasused10. 2. 3. Malnutrition-InflammationScore TheMISquestionnaire8, 9wasusedwithintheroutinenutritionalcareprotocolto assessnutritionalstatusintheoutpatientmedicalACKDunit. Thisscreeningtoolincludes tencomponents: sevensubjective(obtainedfrommedicalhistoryandphysicalexams), and threeobjectiveparameters(s-albumin, totalbindingironcapacity, andbodymassindex (body mass index). TheMIScomponentsrangefrom0(normal)to30(severelywasted). Althoughthe well-nourishedpatientswereconsideredfrom0to2, inagreementwithotherstudies, protein-energy wasting wasdefinedasanMIS≥5points26, 27. 2. 4. AnthropometricMeasuresandBodyCompositionAnalysis Bodyweight(BW)andBMIwererecordedasanthropometricmeasures. Thehandgrip strength(HGS)oftherighthandwasmeasuredwithahand-helddynamometer(Baseline mod. 12-0240). The measurements were taken in triplicate and the mean of the values obtainedwasrecorded. Bodycompositionwasevaluatedwithabioelectricalimpedanceanalyzer(BIA-101, Akern-RJLSystems, Florence, Italy)atafrequencyof50kHzand800µAconstantelectricalflowthroughthebodyinthehorizontalsupineposition. Tetrapolardistalvalidated method28byusingtwopairsofdisposableelectrodes(BiatrodesTM100S, Akern, Florence, Italy)placedontherighthandandfootandwhole-bodyBIAwasperformed. In patientswithanarteriovenousfistulainthedominantarm, anthropometricandmuscle strengthmeasurementswerecarriedoutonthecontralateralside. BIA-derivedmeasurementssuchasPA, exchangeableNa/potassium, TBW, ECW, intracellularwater(ICW), bodycell mass(BCM), FFM, andMMwereanalysedbyBodygramProV. 3. 0softwarebasedonmanufacturers standards. In accordance with previous studies in chronic kidney disease patients 27, 29, 30, the cut-off point to be wasted for PA was 4. According to the sarcopenia consensus20forclassifyingHGSmeasuresnormalcut-offpointsforwomen16kg/m2 and men27kg/m2 wereusedinthisstudy. Variousstudies3133demonstratedthatlow valuesofHGSweresignificantpredictorsofsurvivalinCKD. Nutrients2022, 14, 3848 5of15 2. 5. LaboratoryParameters Laboratorysampleswereretrospectivelycollectedfrommedicalrecords. S-albumin wasanalyzedbythecolorimetricstandardmethod(Roche/Hitachi904/ModularACN 413)usingthebromocresolgreenmethod34. BasedonthediagnosticcriteriaforPEW6, the cut-off point for s-albumin was on at 3. 8 grams per deciliter. s-Prealbumin and s-CRP were measuredbyimmunoturbidimetrymethods(Roche/Hitachi904/ModelP: ACN218, Roche Diagnostics, Basel, Switzerland). The concentration of s-CRP (non-High sensitivity) was consideredasaninflammatorymarkersetonacut-offpointatorabove1mg/dL. 2. 6. StatisticalAnalysis Continuousvariableswereexpressedasmeanandstandarddeviation, withthecomparisonsbetweengroupsperformedbytheANOVA-factortestfornormallydistributed variables. Categorical variables were defined using proportions and were analyzed by theChi-squaredtest. CorrelationsweretestedbybivariatePearsoncorrelationsforcontinuousvariables. TheKaplanMeiermethod33wasusedtocalculatecumulativesurvivalprobabilitiesaccordingtothedifferentcut-offpoints(age: 72years; MIS: 5points; s-prealbumin: 30 milligrams per deciliter; PA: 4, and HGS gender-adjusted). The difference between survivalcurveswas assessedbythe log-ranktest.",
    "TheKaplanMeiermethod33wasusedtocalculatecumulativesurvivalprobabilitiesaccordingtothedifferentcut-offpoints(age: 72years; MIS: 5points; s-prealbumin: 30 milligrams per deciliter; PA: 4, and HGS gender-adjusted). The difference between survivalcurveswas assessedbythe log-ranktest. Univariate andmultivariateCoxproportional hazard regression analyses were used to evaluate the prognostic value of the differentparametersandtheriskofdeath. Thevariablesthatsignificantlyaffectedsurvival intheunivariateanalysisweresubsequentlytestedinmultivariatemodelsusingaforward stepwiseprocedurewithaprobabilitytotheentryof0. 05andaprobabilityofremovalof 0. 20. ThemultivariateCoxproportionalhazardmodelwasadjustedforageandgenderas potentialconfounders. Thehazardratio(heart rate)and95%confidenceinterval(95%CI)were calculated. StatisticalanalyseswereperformedbyusingSPSSversion23. 0(IBMCorp. , Armonk, NY, USA)software. p-values0. 05weresetassignificant. 3. Results 3. 1. GlobalDataandComparisonbetweenGroups Ofthe307patientswithCKDwhoparticipatedinthisstudy, 61. 90%weremen, the meanagewas70. 16±12. 46years. TheglobalprevalenceofDMwas46. 30%inthesample, beingtheprimaryetiologyleadingtoCKDin23. 0%ofthepatientsinthisstudy. SixtytwoCKDpatients(20. 19%)diedat10yearsoffollow-up. Eighty-fourpatientswithCKD (27. 30%) were censored as the main cause of onset of RRT. The causes of death were cardiovascular disease (n 21; 34. 40%), cerebrovascular disease (n 5; 8. 19%), infection (n 9; 14. 75%), neoplasm (n 9; 14. 70%), and unknown cause (n 13; 21. 0%). The demographic and clinicalcharacteristicsofthe307ACKDpatientsaresummarizedinTable1. Table1. Demographicandclinicalcharacteristicsof307advancedchronickidneydiseasepatients. Global NoSurvivors Survivors Censored Variables p-Value n307 n62 n161 n84 Malen; (%) 212(61. 90) 36(58. 10) 113(70. 20) 63(75. 0) 0. 003 Age(years) 70. 16±12. 46 68. 72±12. 43 77. 55±9. 66 67. 10±12. 33 0. 001 DMn(%) 142(46. 30) 28(45. 20) 76(47. 20) 38(45. 20) 0. 940 TimeACKDunit(mo. ) 58. 89±37. 59 32. 82±24. 93 64. 09±63. 29 23. 63±19. 93 0. 001 e-glomerular filtration rate(milliliters per minute/1. 73m2) 18. 96±8. 24 19. 38±7. 75 20. 78±8. 85 15. 16±5. 82 0. 001 nPna(g/kg/day) 0. 92±0. 24 0. 90±0. 20 0. 94±0. 28 0. 90±0. 20 0. 608 protein-energy wastingn(%) 83(27. 0%) 24(38. 70%) 37(23. 0%) 22(26. 20) 0. 049 p-ValuesarebasedonChi-squareorANOVAfactortests. protein-energy wasting, Protein-energywastingwasassessedby malnutrition-inflammationscore(MIS)questionnaireequaltoorhigherthan5points. ACKD-unit, advanced chronickidneydiseaseunit; diabetes mellitus, diabetesmellitus; e-glomerular filtration rate, estimatedglomerularfiltrationrate; nPna, normalized proteinnitrogenappearance. Nutrients2022, 14, 3848 6of15 AccordingtoCKDstage, 30patientswereinCKDstage3b(9. 80%), whiletherewere 164 patients in chronic kidney disease stage 4 (53. 40%) and 113 patients in chronic kidney disease stage 5 without Dialysis (36. 80%). ThemeantimeintheACKDunitwas58. 89±37. 59months. Themeanvalue ofe-GFRwassignificantlyhigherinsurvivorsthaninno-survivorsandcensoredCKD patients(p0. 001), whilenPnadidnotdifferbetweenthethreegroups. ThetotalMIS valueswere4. 14 ± 3. 19points, beinghigherinnon-survivors(MIS: 4. 54 ± 3. 08points) thaninsurvivors(MIS: 3. 88±3. 12points)orcensoredpatients(MIS: 4. 34±3. 39points) (p0. 30). ByanalyzingMIS≥5pointsasPEWcriteria, wassignificantlymuchhigherin non-survivorsthaninsurvivororcensoredgroups(Table1). MISwaspositivelycorrelated with age (r 0. 268; p 0. 01), s-CRP (r 0. 185; p 0. 01), TBW (r 0. 252; p 0. 01) and negatively with s-prealbumin (r 0. 229; p 0. 01), ICW (r 0. 226; p 0. 01), BCM% (r0. 186; p0. 001), PA(r0. 238; p0. 01)andright-HGS(r0. 132; p0. 05). 3. 2. AnthropometricMeasures, BodyCompositionAnalysis, andLaboratoryData Table2showsbodycompositionandlaboratorydataofnosurvivor, survivor, and censored groups. BW and body mass index did not differ significantly between groups. The mean valueBMIwasconsistentwithoverweightinallthreegroupsanalyzed. AccordingtoBMI classification, 38. 10%wereoverweightwhile26. 10%wereobese. Overweightwasfound morecommonlyinmales(41. 30%)vs. females(30. 50%), whereasobesitywassimilarin bothgenders(male: 25. 40%; female: 27. 30%). Survivorswereoverweight(37. 80%)and obese(29. 80%)comparedtonon-survivors(40. 30%and20. 90%, respectively). Table2. Anthropometric, bodycomposition, andlaboratoryparametersin307advancedchronic kidneydiseasepatients. Global NoSurvivors Survivors Censored Variables p-Value n307 n62 n161 n84 BW(kg) 75. 03±16. 35 71. 61±15. 18 76. 04±17. 17 75. 60±15. 38 0. 181 body mass index(kg/m2) 27. 04±5. 12 27. 14±5. 20 27. 67±5. 24 27. 09±4. 88 0. 634 ExchangeableNa/potassium 1. 44±0. 49 1. 57±0. 58 1. 37±0. 45 1. 47±0. 49 0. 019 TBW(%) 53. 59±6. 93 53. 82±8. 08 52. 91±6. 34 54. 70±7. 04 0. 152 ECW(%) 58. 66±8. 27 56. 66±7. 29 56. 16±8. 57 56. 61±8. 54 0. 018 ICW(%) 42. 99±8. 41 40. 33±7. 29 43. 81±8. 58 43. 38±8. 54 0. 019 BCM(%) 38. 74±9. 37 36. 51±8. 25 40. 19±9. 79 37. 62±8. 95 0. 014 PA() 4. 10±1. 16 3. 72±0. 97 4. 24±1. 19 4. 13±1. 19 0. 012 FM(%) 32. 11±10. 36 31. 94±9. 91 32. 58±9. 15 29. 97±9. 57 0. 123 FFM(%) 68. 35±9. 48 67. 88±10. 36 67. 67±8. 99 70. 01±9. 58 0. 168 MM(%) 33. 18±7. 88 32. 02±7. 39 33. 30±8. 21 33. 81±7. 57 0.",
    "99 70. 01±9. 58 0. 168 MM(%) 33. 18±7. 88 32. 02±7. 39 33. 30±8. 21 33. 81±7. 57 0. 386 Right-HGS(kg/m2) 25. 78±9. 90 21. 04±7. 72 27. 19±10. 27 26. 51±9. 64 0. 001 s-Albumin(grams per deciliter) 4. 10±4. 47 4. 10±0. 39 4. 21±0. 44 4. 15±0. 45 0. 231 s-Prealbumin(milligrams per deciliter) 28. 30±6. 83 25. 83±5. 21 28. 61±6. 60 29. 53±7. 81 0. 005 s-CRP(milligrams per deciliter) 0. 82±1. 49 0. 59±0. 73 0. 98±1. 86 0. 71±1. 01 0. 158 p-ValuesarebasedonANOVA-factortest. BCM, bodycellmass; body mass index, bodymassindex; BW, bodyweight; ECW, extracellularwater; FFM, fat-freemass; FM, fatmass; ICW, intracellularwater; MM, musclemass; PA, phaseangle; Right-HGS, righthandgripstrength; s-Albumin, serumalbumin; s-CRP, serumC-reactiveprotein; s-Prealbumin, serumprealbumin; TBW, totalbodywater. SurvivorshadsignificantlylowerexchangeableNa/KandECWthannon-survivors (atleast, p0. 05), whilehighersignificantmeasuresofICW%, BCM%, andPAwerealso found in the survivor group. Body composition measurements such as FM, FFM, and MMtendedinanon-significantmannertobehigherinsurvivors. Overall, itshouldbe noted that 47. 40% had dynapenia. Mean right-HGS values were significantly lower in non-survivors than in the survivor or censored groups. Analyzing by gender, in male non-survivors, 57. 10% had a right-HGS 27 kg/m2, while in survivors, it was 27. 40% (p0. 046). Infemales, right-HGSwas16kg/m2in80. 80%ofnon-survivorsandin66. 70% ofsurvivors(p0. 001). Nutrients2022, 14, 3848 7of15 Globally, 32. 30% of patients had MIS ≥ 5 points, mean s-albumin values of 3. 94±0. 58g/dL, ands-CRPvaluesof1. 13±1. 90mg/dL. Themeans-albuminconcentrationwas4. 10±0. 43g/dL, withnosignificantdifferencesbetweenthegroups. S-albumin concentration3. 8g/dLwasfoundin17. 12%ofsurvivorsand19. 35%ofnon-survivors (p0. 99). s-AlbuminwaspositivelycorrelatedwithICW%(r0. 372; p0. 001), BCM% (r0. 304; p0. 001), right-HGS(r0. 159p0. 005), andnPna(r0. 281; p0. 001)andnegativelywithage(r0. 213; p0. 001), TBW%(r0. 257; p0. 001), ECW%(r0. 372; p0. 001), exchangeNa/potassium(r0. 431; p0. 001), MIS(r0. 467; p0. 001), ands-CRP (r0. 315; p0. 001). Means-prealbuminlevelswereslightlylowerinnon-survivorscomparedtosurvivors (25. 83±5. 21vs. 28. 61±6. 60)orcensored(29. 53±7. 81mg/dL)groups(p0. 005)along withlowlevelsofs-CRPbetweengroups(p0. 05). s-Prealbuminwaspositivelycorrelated withage(r0. 380; p0. 001), ICW%(r0. 392; p0. 001), BCM%(r0. 284; p0. 001), and right-HGS(r0. 248; p0. 001)andnegativelywithMIS(r0. 225; p0. 001)ands-CRP (r0. 303; p0. 001). Only16. 1%ofnon-survivors, 19. 30%ofsurvivors, and21. 40%of censoredpatientshads-CRPlevels1mg/dL(p0. 724). 3. 3. FactorsPredictingMortality Nutrients 2022, 14, x FOR PEER REVIEW Theresultsofthesurvivalcurveanalysesshowedmeanage(72years. ), MIS8 o5f p1o5i nts, PA≤4, s-prealbumin≤30mg/dL, andthelowestgender-adjustedHGScut-offpoint usingright-HGSwerepredictorsofmortalityinpatientswithstage3b, 45CKD, asshown inFigures2and3. Figure 2. KaplanMFeiigeurr esu2. rvKiavpalla ncuMrveeiesr osuf rtvhivea sltcuudrvye spoafrtthiceipstaundtys psatrrtaictiipfiaendts bsytr atthifiee cdubty-otfhfe-pcouti-notfsfpoofi nts (a) age (≤72 vs. 72 oyfe(aar)sa)g aen(≤d7 (2bv)s. ma7l2nyuetarrist)ioannd-in(bf)lammalmnuattriitoionn s-icnoflraem (mMaItSio: n ≤s5c ovrse. ( M5I Sp: o≤i5nvtss). a5s pmooinrt-s)as tality risk predictorsm ionr tsatlaitgyeri s3kbp, r4ed5ic ctohrrsoinniscta kgeid3nb, e4y 5dcisheroansiec pkiadtnieeyndtsi. s easepatients. Nutrients 2022, 14, x FOR PEER REVIEW 8 of 15 Figure 2. KaplanMeier survival curves of the study participants stratified by the cut-off-points of (a) age (≤72 vs. 72 years) and (b) malnutrition-inflammation score (MIS: ≤5 vs. 5 points) as morNutrients2t0a2l2i, t1y4, r3i8s4k8 predictors in stage 3b, 45 chronic Kidney disease patients. 8of15 Figure3. KaplanMeiersurvivalcurvesofthestudyparticipantsstratifiedbythecut-off-pointsof (a)phaseangle(PA: ≤4vs. 4), (b)s-Prealbumin(≤30vs. 30mg/dL), and(c)handgripstrength inmales(HGS: ≤26vs. 26kg/m2)andinfemales(HGS: ≤17vs. 17kg/m2)asmortalityrisk predictorsinstage3b, 45chronickidneydiseasepatients. 3. 4. CoxProportionalHazardsAnalysisofMortality The univariate Cox proportional hazards analysis results showed that parameters such as age, time on ACKD unit, MIS, or body composition measurements including exchangeable sodium/potassium, ECW%, ICW%, BCM%, PA, right-HGS as well as s-albumin and s-prealbuminwerepredictorsofmortalityriskat10yearsoffollow-up(Table3). Nutrients2022, 14, 3848 9of15 Table3. Univariate Cox proportional hazards analysis of all-cause mortality risk in stage 3b, 45chronickidneydiseasepatients. PredictorVariable heart rate(95%CI) p-Value Gender 1. 530(0. 926to2. 528) 0. 097 Age(years) 1. 071(1. 071to1. 101) 0. 001 DMn; (%) 0. 161(0. 549to1. 486) 0. 688 TimeACKD-unit(months) 0. 978(0. 969to0. 986) 0. 001 e-glomerular filtration rate(milliliters per minute/1. 73m2) 1. 008(0. 979to1. 038) 0. 587 nPna(g/kg/day) 0. 529(0. 156to1. 794) 0. 307 MIS(points) 1. 080(1. 005to1. 161) 0. 036 BW(kg) 0. 989(0. 973to1. 005) 0. 178 body mass index(kg/m2) 0. 997(0. 949to1. 047) 0. 899 ExchangeableNa/potassium 1. 669(1. 169to2. 385) 0. 005 TBW(%) 1. 004(0. 968to1. 041) 0. 838 ECW(%) 1. 056(1. 026to1.",
    "899 ExchangeableNa/potassium 1. 669(1. 169to2. 385) 0. 005 TBW(%) 1. 004(0. 968to1. 041) 0. 838 ECW(%) 1. 056(1. 026to1. 087) 0. 001 ICW(%) 0. 947(0. 920to0. 975) 0. 001 BCM(%) 0. 968(0. 942to0. 995) 0. 021 PA() 0. 650(0. 513to0. 824) 0. 001 FM(%) 0. 397(0. 982to1. 035) 0. 529 FFM(%) 0. 377(0. 966to1. 018) 0. 539 MM(%) 0. 969(0. 937to1. 002) 0. 068 Right-HGS(kg/m2) 0. 946(0. 919to0. 973) 0. 001 s-Albumin(grams per deciliter) 0. 592(0. 355to0. 987) 0. 045 s-Prealbumin(milligrams per deciliter) 0. 936(0. 900to0. 973) 0. 001 s-CRP(milligrams per deciliter) 0. 954(0. 762to1. 194) 0. 680 BCM, bodycellmass; body mass index, bodymassindex; BW, bodyweight; diabetes mellitus, diabetesmellitus; ECW, extracellular Water; e-glomerular filtration rate, estimatedglomerularfiltrationrate; FFM, fat-freemass; FM, fatmass; ICW, intracellularwater; MIS, malnutrition-inflammationscore; MM, musclemass; nPna, normalizedproteinnitrogenappearance; PA, phaseangle; Right-HGS, righthandgripstrength; s-Albumin, serumalbumin; s-CRP, serumC-reactiveprotein; s-Prealbumin, serumprealbumin; TBW, totalbodywater. UsingCoxmultivariateproportionalhazardsanalysis, afteradjustingforpotential confounders(ageandgender), severalparameters, suchasfollow-uptimeintheACKD unit, s-prealbumin, andright-HGSweresignificantlyassociatedwiththeriskofall-cause mortalityinCKDpatients(Table4). Table4. MultivariateCoxproportionalhazardsanalysisofall-causemortalityriskinstage3b, 45chronickidneydiseasepatients. PredictorVariable heart rate(95%CI) p-Value Timeoffollow-up(months) 0. 975(0. 966to0. 984) 0. 001 s-Prealbumin(milligrams per deciliter) 0. 946(0. 911to0. 982) 0. 003 Right-HGS(kg/m2) 0. 953(0. 925to0. 983) 0. 002 p-Value was adjusted for age and gender as confounding factors. heart rate, hazard ratio; Right-HGS, right handgripstrength. 4. Discussion Theresultsofthisstudydemonstratethatregularclinicalandnutritionalcareand follow-upusingacombinationofnutritional, bodycomposition, andfunctionalparameters contributetoimprovedsurvivalofCKDpatientsduring10yearsoffollow-upinamultidisciplinaryACKDunit. Inthisstudy, patientswithACKDwereolder, moreoftenmale, andweremostlyinCKDstages45(90. 50%). ThemainetiologyleadingtoCKDwasDM (23. 0%), includinganoverallhighproportionofdiabeticsdiagnosedinthestudyforother causes(46. 30%). Follow-uptimeintheACKDunitwaslongerthanoneyearin75. 20% ofpatients. Infact, inthespecificmonographicACKDUnit, patientswithCKDwereassessedandfollowedupmedicallyandnutritionallyfromtheperspectiveofcomprehensive managementofmodifiableriskfactorsforCKDprogressionandcardiovascularrisk(diabetes mellitus, hypertension, dyslipidemia, proteinuria, anduricacid), aswellascontrolofanemia, bone Nutrients2022, 14, 3848 10of15 mineralmetabolism, underlyingcomorbidities, andnutritionalstatus, ascomponentsof thecomprehensiveandmultifactorialapproachtotheCKDpatient. Notably, amulticentre, randomized, open-label, multicentreclinicaltrialindiabeticpatientswithCKD35 comparedtheintensivemultifactorialtreatmentofmortalityriskfactors(bloodpressure control, glycatedhemoglobin, totalcholesterol, LDLandHDL)withstandardmedicalcare onmajorfatal/non-fatalCVevents. At13yearsoffollow-up, thestudydemonstratedthat onlythestrategybasedontheintensivetreatmentofmajorriskfactorswaseffectivein reducingallcausesofmortalityby47. 0%35. ResultsfromthisstudyshowedthatCVD, cerebrovasculardiseaseandDMamongotherriskfactorswerethemaincausesofdeathin CKDpatients, inaccordancewithpreviousstudies. Themaincausesofdeathindiabetics werecardiovascularevents(4. 20%), cancer(4. 20%), andinfectionsincludingsepsis(3. 50%) inthisstudy. Inthecurrentstudy, theevolutionofCKDpatientswasanalyzedconsideringnondeathcausesforleavingthestudy: onsetofRRT, transferorlosstofollow-up, orliving donorrenaltransplantation. Inthesescenarios, follow-upuntiltheeventwasconsidered, takingintoaccountthemainfeaturesofthecensored, surviving, andnon-survivinggroups inthe307CKDpatientsanalyzed. Inthepresentstudy, itwasfoundthat20. 19%ofCKDpatientshaddiedwithamean follow-upintheACKDunitof32. 82±24. 93months. Theleadingcausesofdeathwere cardiovascular disease, cancer, andinfections. Infact, age≥72yearsoroverwasasignificantriskfactorfor mortality(Figure2). Olderageisinherentlyacontributoryfactortoadverseoutcomesin CKDassociatedwithincreasedcomorbidities(e. g. , cardiovascular disease)andahigherriskofPEWand inflammation with declining Kidney function 36. It should be noted that protein-energy wasting can be triggeredinanyagerangeandiscloselyrelatedtotheacuteintercurrentprocessesand multiplecomorbiditiesthatoftenaccompanypatientswithCKD. protein-energy wasting is a common condition in patients with chronic kidney disease and a recognized predictor of mortalityassociatedwithCVD. TheresultsofthisstudyshowedthatPEW, asmeasured byMISscore≥5points, was27. 0%inCKDpatientsfollowedfor10years. Thesefindings areremarkablylowerthanthosefoundinothersimilarstudies37inCKDstages3b, 45. AlowprevalenceofPEW28. 0%isobservedintheearlystagesofCKD, whichgradually increasesasCKDprogressesandevenreaches70. 0%inCKDstage55, 38. TheMISquestionnaireisavalidatedandusefulnutritionalscreeningtoolthathas been shown to be effective as an independent predictor of mortality in chronic kidney disease and dialysis patients 39. In this study, non-survivors had a significantly higher frequency of MIS≥5points compared with survivors or censored groups. MIS was positively associated with age, TBW, and s-CRP and inversely with BCM (%), PA, s-prealbumin, and right-HGS(atleast, p0. 05). Inaddition, MIS≥5pointswereasshowntobeariskfactorin theKaplanMeieranalysis(Figure2, Table3)andasignificantpredictorofmortalityinthe univariateanalysis(heart rate: 4. 38; CI95%: 1. 0051. 161; p0. 036). IntheACKDunit, theperiodicalmonitoringofnutritionalstatusprovidesearlyidentificationandtreatmentofPEWand avoidsitsevolutiontosevereandirreversiblegradesassociatedwithinflammationsuchas cachexia5, 9, 26, 27, 40. Conversely, meanBMIvalueswereassociatedwithoverweightin thisstudy. ByanalyzingBMIcategories, non-survivorsweremoreobese29. 80%compared withsurvivorswhoonly21. 0%wereobese. Previousstudies41, 42haveshowninstage 35CKD that overweight and mild obesity as measured by body mass index provides advantages in terms of chronic kidney disease progression and overall survival, whereas a BMIvalue23kg/m2 increasedtheriskofmortality. Moreover, meanBMIvalueswereassociatedwithoverweight, althoughwithoutsignificantdifferenceswithcumulativesurvivalinthisstudy. BIA is a simple and non-invasive technique for measuring body composition and hydrationstatusinCKDanddialysispatients. Inthecurrentstudy, BIA-derivedmeasurements(BCM, PA), aswellashydrationindicators(exchangeableNa/potassium, ECW, ICW), were significantly different between survivor and non-survivor groups (all, at least, p 0. 05) (Table2). InCKDpatients, lowBCMwasrelatedwithearlyPEW, reductioninMM, and decreasedHGS43. Inaddition, PAisacell-integritypredictorofmorbidityandmortality Nutrients2022, 14, 3848 11of15 inCKDpatients. SignificantmeanPAvaluedifferenceswerefoundbetweennon-survivors andsurvivors. ItisworthnotingthatthemedianPAinthisstudywas4. Acut-offpoint ofPA≥4 hasbeenshowntobeaprotectiveindicatorofnutritionalstatusinCKDand Dialysis patients 4446. The results of this study showed that PA ≥ 4 was found in 41. 90%ofnon-survivorsand53. 40%ofsurvivors, whichwassignificantlydemonstrated byCoxregressionsurvivalcurvesandunivariateanalysis. Clinicalresearchstudieson chronic kidney disease44, 47, 48showedthatPAwaspositivelyassociatedwiths-albuminands-prealbumin concentrations, FFMfromBIA, andHGSalongwithCVeventsormortality. Thefindingsof thisstudyarealsoconsistentwiththoseofpreviousstudiesinwhichPA≥4wasshownto beapredictorofnutritionalriskandmortalityinCKDanddialysispatients18, 19, 47. Inaddition, KaplanMeiersurvivalanalysisrevealedthatpatientswithPA4hadsignificantly longersurvival, asshowninFigure3. TheHGSisanindirectmeasureofskeletalmuscleperformance, aswellasbeingoneof thecommonlyrecognizeddiagnosticcriteriaforsarcopenia. Resultsfromthisstudyshowed thatsignificantdifferenceswithright-HGSadjustedbyconventionalgendercut-offswere foundbetweennon-survivorscomparedwiththesurvivorandcensoredgroups. Maleand femalenon-survivorshadsignificantlylowerHGSvaluesthansurvivors, with32. 90%of non-survivorshavingnormalvalues, aswellas60. 90%ofsurvivorsand51. 20%ofcensored survivors. In fact, the predictive ability of the HGS cut-off points (male: 27kg/m2 or female: 16kg/m2)wassignificantlyconfirmedinthesurvivalcurves(long-ranktest8. 243; p0. 004)(Figure3c). Furthermore, theresultsobtainedinunivariateandmultivariate analysesshowedthatHGSwasasignificantprotectivefactorformortalityat10yearsof follow-up. Arecentstudyof8767patientswithCKD31reportedthat9. 70%werelikely tobesarcopenic, whilethe10-yearssurvivalprobabilitywas85. 0%insarcopenicpatients comparedtonon-sarcopenicpatientswithCKD(89.",
    "243; p0. 004)(Figure3c). Furthermore, theresultsobtainedinunivariateandmultivariate analysesshowedthatHGSwasasignificantprotectivefactorformortalityat10yearsof follow-up. Arecentstudyof8767patientswithCKD31reportedthat9. 70%werelikely tobesarcopenic, whilethe10-yearssurvivalprobabilitywas85. 0%insarcopenicpatients comparedtonon-sarcopenicpatientswithCKD(89. 0%). S-albumin is an independent predictor of morbidity and mortality in ACKD and dialysispatients11, 12, 14, 17. Inthisstudy, means-albuminlevelsdidnotdiffersignificantlybetweennosurvivorsandsurvivorgroups. s-Albuminwas≥3. 8g/dLin80. 6%of non-survivors, 80. 7%ofsurvivors, and81%ofcensoredCKDpatients. Univariateanalysis showed that s-albumin was an independent risk factor for mortality, but no significant association was found in the multivariate analysis. As a possible explanation for these findings, itshouldbenotedthatthemeans-albuminlevelsinthisstudywere4g/dL, being theseresultsconsistentwithalowfrequencyofPEWandinflammationinthestudy. In addition, s-prealbuminwastestedasanearlymarkerofproteinandinflammatoryprofile. S-prealbuminwassignificantlydifferentbetweengroups, beingfoundatprealbumin levels30mg/dL in 25. 80% of non-survivors and 50. 3% of the survivors (39. 30% censored). KaplanMeieranalysisshowedthatas-prealbumin30mg/dLwasasignificant survivalfactor, afindingalsosupportedbymultivariateCoxregressionata10-yearfollowup (Figure 3b). The findings of this study are in agreement with previously published studies1114, 17inwhichboths-albuminands-prealbuminwerefoundtobemarkersof morbidityandmortalityinCKDanddialysispatients. Somestrengthsandweaknessesofthisstudyshouldbenoted. Toourknowledge, this isthefirststudyinpatientswithACKDthatevaluatesvariouspredictorsofnutritional risk with mortality in a sample of patients with stage 3b, 45 chronic kidney disease with follow-up for 10years. Sofar, studiesinACKDstages45analyzingthepredictiveabilityofvarious nutritionalindicatorsofmortalityriskarestillscarce. However, thisstudyislimitedby thefactthatitwasperformedinasingleACKDunit, andtherefore, possiblebiasesmay haveinterferedwiththestudyresults. Onlyonemeasurementofeachofthenutritional parametersandindicatorswastakenintoaccountretrospectively. Thedatawereextracted retrospectivelyfromthenutritionalhistoryofeachpatientconsideringaminimumtime 3monthsintheACKDunitandtakingintoaccountthatthepatienthadatleastthree consecutivemedicalandnutritionalvisitsfordatacollection. Inaddition, drugtherapy (antihypertensives, diuretics, lipid-loweringagents, antiplateletagents, oralantidiabetic agents, and/orinsulin)andsomemarkersofCVrisk, anemiacontrol, andbonemetabolism, Nutrients2022, 14, 3848 12of15 aswellasotherassociatedcomorbidities, werenotincludedamongthelaboratoryparameterscollectedinthisstudy. Themonitoringoftheseclinicalfactorswasapartoftheroutine comprehensive and multifactorial management of patients in the ACKD unit. Thus, a combination of nutritional, inflammatory, and body composition parameters was used inaccordancewiththeaimofthestudy. Nutritionalassessmentandperiodicfollow-up togetherwithnutritionalcounselingandevaluationofadherencetodietaryrecommendations(lowcontentofprotein, saturatedfat, sugars, phosphorous, phosphorous/Protein ratio, Potassium, andfree-saltdiet)arepartofthecomprehensivecareandattentionofthe CKDpatientintheACKDunit. Asalimitation, inthisstudy, theassessmentofdietary intakewasnotincluded, althoughindirectsurrogatemarkerssuchasnPna, bloodpressure controlaswellasserumsodiumandpotassiumlevelswereusedtoassessadherenceto individualizednutritionalrecommendationsinCKDpatients. Nevertheless, acombination ofnutritional, inflammatory, andbodycompositionparameterswerewidelyused, although drugtreatmentordietaryintakewasnotrecordedinthestudy. Furthermore, inclinical practice, achieving normal albumin values (≥3. 8 grams per deciliter) due to adequate dietary intake and/or Low inflammation may be limiting for the identification of certain classical risk factorssuchasmusclewastingorsarcopenia. Thus, regularmonitoringofnutritionalstatus wascarriedoutbyamultidisciplinaryteamcomposedofanephrologist, anurse, anda nutritionistaspartofthecomprehensiveandpersonalizedcareintheACKDunit. 5. Conclusions Inconclusion, thisstudysuggeststhatnutritionalmonitoringinpatientswithstage3b, 45CKDhelpstoidentifyandtreatnutritionalriskearlyandimproveadversemortality prognosis. FactorssuchasageandCKDitselffavorPEWwhiletimeonCKDandclinical andnutritionalmonitoring, togetherwiths-prealbuminlevelsandHGSmeasures, were allpotentiallymodifiableparametersthatreducedmortalityinCKDstages3b-5during 10years of follow-up in the multidisciplinary ACKD unit. Further studies are needed to define the impact of nutritional monitoring on mortality risk in ACKD patients on non-Dialysis. AuthorContributions: G. B. , A. N. (AngelNogueira)andG. A. -G. areamultidisciplinaryteamof ACKDUnitthathavedevelopedthemonitoringofnutritionalcare. G. B. , A. N. (AngelNogueira) andM. R. developedthedesign, methodology, andplanningstatisticalanalysis. Investigation: A. N. (AngelNogueira), G. A. -G. , A. N. (AlmudenaNúñez)andC. S. -G. participatedasinvestigatorsin thereviewofmedicalrecordsbyenteringdataintothedatabase. G. B. andM. R. wrotethedraft manuscript. Allauthorshavereadandagreedtothepublishedversionofthemanuscript. Funding: Thisresearchreceivednoexternalfunding. InstitutionalReviewBoardStatement: ThestudywasconductedinaccordancewiththeDeclarationofHelsinkiandapprovedbytheInstitutionallocalReviewBoardofHospitalUniversitario LaPrincesa. InformedConsentStatement: Writteninformedconsentwasdescribedinthematerialandmethod Section. DataAvailabilityStatement: Notapplicable. Acknowledgments: Wewouldliketoacknowledgethecollaborationofallparticipantsandstaff oftheACKDmultidisciplinaryunit(Nephrologist, Nurses, andNutritionists)fromtheHospital UniversitariodelaPrincesadeMadrid. Spain. ConflictsofInterest: Theauthorsdeclarenoconflictofinterest. Nutrients2022, 14, 3848 13of15 References 1. Foreman, potassium. J. ; Marquez, N. ; Dolgert, A. ; Fukutaki, potassium. ; Fullman, N. ; McGaughey, M. ; Pletcher, M. A. ; Smith, A. E. ; Tang, potassium. ; Yuan, C. W. ; etal. Forecastinglifeexpectancy, yearsoflifelost, andall-causeandcause-specificmortalityfor250causesofdeath: Referenceandalternativescenariosfor2016-40for195countriesandterritories. Lancet2018, 392, 20522090. CrossRef 2. Bikbov, B. ; Purcell, C. A. ; Levey, A. S. ; Smith, M. ; Abdoli, A. ; Abebe, M. ; Adebayo, O. M. ; Afarideh, M. ; Agarwal, S. potassium. ; AgudeloBotero, M. ; etal. Global, regional, andnationalburdenofchronickidneydisease, 19902017: AsystematicanalysisfortheGlobal BurdenofDiseaseStudy2017. Lancet2020, 395, 709733. CrossRef 3. Minutolo, R. ; Sasso, F. C. ; Chiodini, P. ; Cianciaruso, B. ; Carbonara, O. ; Zamboli, P. ; Tirino, G. ; Pota, A. ; Torella, R. ; Conte, G. ; etal. Managementofcardiovascularriskfactorsinadvancedtype2diabeticnephropathy: Acomparativeanalysisinnephrology, diabetologyandprimarycaresettings. J. Hypertens. 2006, 24, 16551661. CrossRef 4. Sasso, F. C. ; DeNicola, L. ; Carbonara, O. ; Nasti, R. ; Minutolo, R. ; Salvatore, T. ; Conte, G. ; Torella, R. Cardiovascularriskfactors anddiseasemanagementintype2diabeticpatientswithdiabeticnephropathy. DiabetesCare2006, 29, 498503. CrossRef 5. Hanna, R. M. ; Ghobry, L. ; Wassef, O. ; Rhee, C. M. ; Kalantar-Zadeh, potassium. APracticalApproachtoNutrition, Protein-EnergyWasting, Sarcopenia, andCachexiainPatientswithChronicKidneyDisease. BloodPurif. 2020, 49, 202211. CrossRefPubMed 6. Fouque, D. ; Kalantar-Zadeh, potassium. ; Kopple, J. ; Cano, N. ; Chauveau, P. ; Cuppari, L. ; Franch, H. ; Guarnieri, G. ; Ikizler, T. A. ; Kaysen, G. ; etal. Aproposednomenclatureanddiagnosticcriteriaforprotein-energywastinginacuteandchronickidneydisease. Kidney Int. 2008, 73, 391398. CrossRef 7.",
    "Aproposednomenclatureanddiagnosticcriteriaforprotein-energywastinginacuteandchronickidneydisease. Kidney Int. 2008, 73, 391398. CrossRef 7. Ikizler, T. A. ; Cano, N. J. ; Franch, H. ; Fouque, D. ; Himmelfarb, J. ; Kalantar-Zadeh, potassium. ; Kuhlmann, M. potassium. ; Stenvinkel, P. ; Terwee, P. ; Teta, D. ; etal. Preventionandtreatmentofproteinenergywastinginchronickidneydiseasepatients: Aconsensusstatementby theInternationalSocietyofRenalNutritionandMetabolism. KidneyInt. 2013, 84, 10961107. CrossRef 8. Kalantar-Zadeh, potassium. ; Kopple, J. D. ; Block, G. ; Humphreys, M. H. Amalnutrition-inflammationscoreiscorrelatedwithmorbidity andmortalityinmaintenancehemodialysispatients. Am. J. KidneyDis. 2001, 38, 12511263. CrossRef 9. Amparo, F. C. ; Kamimura, M. A. ; Molnar, M. Z. ; Cuppari, L. ; Lindholm, B. ; Amodeo, C. ; Carrero, J. J. ; Cordeiro, A. C. Diagnostic validationandprognosticsignificanceoftheMalnutrition-InflammationScoreinnondialyzedchronickidneydiseasepatients. Nephrol. Dial. Transplant. 2015, 30, 821828. CrossRef 10. Ikizler, T. A. ; Cuppari, L. The2020UpdatedKDOQIClinicalPracticeGuidelinesforNutritioninChronicKidneyDisease. Blood Purif. 2021, 50, 667671. CrossRef 11. Foley, R. N. ; Parfrey, P. S. ; Harnett, J. D. ; Kent, G. M. ; Murray, D. C. ; Barre, P. E. Hypoalbuminemia, cardiacmorbidity, andmortality inend-stagerenaldisease. J. Am. Soc. Nephrol. 1996, 7, 728736. CrossRefPubMed 12. Alves, F. C. ; Sun, J. ; Qureshi, A. R. ; Dai, L. ; Snaedal, S. ; Barany, P. ; Heimburger, O. ; Lindholm, B. ; Stenvinkel, P. Thehighermortality associatedwithlowserumalbuminisdependentonsystemicinflammationinend-stagekidneydisease. PLoSONE2018, 13, e0190410. CrossRefPubMed 13. Mittman, N. ; Avram, M. M. ; Oo, potassium. potassium. ; Chattopadhyay, J. Serumprealbuminpredictssurvivalinhemodialysisandperitoneal Dialysis: 10yearsofprospectiveobservation. Am. J. KidneyDis. 2001, 38, 13581364. CrossRefPubMed 14. Wu, P. P. ; Hsieh, Y. P. ; Kor, C. T. ; Chiu, P. F. AssociationbetweenAlbumin-GlobulinRatioandMortalityinPatientswithChronic KidneyDisease. J. Clin. Med. 2019, 8, 1991. CrossRefPubMed 15. Yeun, J. Y. ; Levine, R. A. ; Mantadilok, V. ; Kaysen, G. A. C-Reactiveproteinpredictsall-causeandcardiovascularmortalityin hemodialysispatients. Am. J. KidneyDis. 2000, 35, 469476. CrossRef 16. Menon, V. ; Greene, T. ; Wang, X. ; Pereira, A. A. ; Marcovina, S. M. ; Beck, G. J. ; Kusek, J. W. ; Collins, A. J. ; Levey, A. S. ; Sarnak, M. J. C-reactiveproteinandalbuminaspredictorsofall-causeandcardiovascularmortalityinchronickidneydisease. KidneyInt. 2005, 68, 766772. CrossRef 17. Chan, M. ; Kelly, J. ; Batterham, M. ; Tapsell, L. Malnutrition(subjectiveglobalassessment)scoresandserumalbuminlevels, but notbodymassindexvalues, atinitiationofdialysisareindependentpredictorsofmortality: A10-yearclinicalcohortstudy. J. Ren. Nutr. 2012, 22, 547557. CrossRef 18. Bansal, N. ; Zelnick, L. R. ; Himmelfarb, J. ; Chertow, G. M. BioelectricalImpedanceAnalysisMeasuresandClinicalOutcomesin chronic kidney disease. Am. J. KidneyDis. 2018, 72, 662672. CrossRef 19. Han, B. G. ; Lee, J. Y. ; Kim, J. S. ; Yang, J. W. DecreasedBioimpedancePhaseAngleinPatientswithDiabeticChronicKidneyDisease Stage5. Nutrients2019, 11, 2874. CrossRef 20. Bauer, J. ; Morley, J. E. ; Schols, A. ; Ferrucci, L. ; Cruz-Jentoft, A. J. ; Dent, E. ; Baracos, V. E. ; Crawford, J. A. ; Doehner, W. ; Heymsfield, S. B. ; etal. Sarcopenia: ATimeforAction. AnSCWDPositionPaper. J. CachexiaSarcopeniaMuscle2019, 10, 956961. CrossRef 21. Vettoretti, S. ; Caldiroli, L. ; Armelloni, S. ; Ferrari, C. ; Cesari, M. ; Messa, P. SarcopeniaisAssociatedwithMalnutritionbutNot withSystemicInflammationinOlderPersonswithAdvancedCKD. Nutrients2019, 11, 1378. CrossRefPubMed 22. Pereira, R. A. ; Cordeiro, A. C. ; Avesani, C. M. ; Carrero, J. J. ; Lindholm, B. ; Amparo, F. C. ; Amodeo, C. ; Cuppari, L. ; Kamimura, M. A. Sarcopeniainchronickidneydiseaseonconservativetherapy: Prevalenceandassociationwithmortality. Nephrol. Dial. Transplant. 2015, 30, 17181725. CrossRefPubMed 23. Souza, V. A. ; Oliveira, D. ; Barbosa, S. R. ; Correa, J. ; Colugnati, F. A. B. ; Mansur, H. N. ; Fernandes, N. ; Bastos, M. G. Sarcopeniain patientswithchronickidneydiseasenotyetondialysis: Analysisoftheprevalenceandassociatedfactors. PLoSONE2017, 12, e0176230. CrossRef Nutrients2022, 14, 3848 14of15 24. Roshanravan, B. ; Robinson-Cohen, C. ; Patel, potassium. V. ; Ayers, E. ; Littman, A. J. ; deBoer, I. H. ; Ikizler, T. A. ; Himmelfarb, J. ; Katzel, L. I. ; Kestenbaum, B. ; etal. Associationbetweenphysicalperformanceandall-causemortalityinCKD. J. Am. Soc. Nephrol. 2013, 24, 822830. CrossRefPubMed 25.",
    "Associationbetweenphysicalperformanceandall-causemortalityinCKD. J. Am. Soc. Nephrol. 2013, 24, 822830. CrossRefPubMed 25. Inker, L. A. ; Eneanya, N. D. ; Coresh, J. ; Tighiouart, H. ; Wang, D. ; Sang, Y. ; Crews, D. C. ; Doria, A. ; Estrella, M. M. ; Froissart, M. ; etal. NewCreatinine-andCystatinC-BasedEquationstoEstimateGFRwithoutRace. N. Engl. J. Med. 2021, 385, 17371749. CrossRef PubMed 26. Rambod, M. ; Bross, R. ; Zitterkoph, J. ; Benner, D. ; Pithia, J. ; Colman, S. ; Kovesdy, C. P. ; Kopple, J. D. ; Kalantar-Zadeh, potassium. Association ofMalnutrition-InflammationScorewithqualityoflifeandmortalityinhemodialysispatients: A5-yearprospectivecohortstudy. Am. J. KidneyDis. 2009, 53, 298309. CrossRef 27. Ruperto, M. ; Sanchez-Muniz, F. J. ; Barril, G. Predictorsofprotein-energywastinginhaemodialysispatients: Across-sectional study. J. Hum. Nutr. Diet. 2014, 29, 3847. CrossRef 28. Lukaski, H. C. ; Bolonchuk, W. W. ; Hall, C. B. ; Siders, W. A. Validationoftetrapolarbioelectricalimpedancemethodtoassesshuman bodycomposition. J. Appl. Physiol. 1986, 60, 13271332. CrossRef 29. Rosler, A. ; Lehmann, F. ; Krause, T. ; Wirth, R. ; vonRenteln-Kruse, W. Nutritionalandhydrationstatusinelderlysubjects: Clinical ratingversusbioimpedanceanalysis. Arch. Gerontol. Geriatr. 2010, 50, e81e85. CrossRef 30. Tabinor, M. ; Elphick, E. ; Dudson, M. ; Kwok, C. S. ; Lambie, M. ; Davies, S. J. Bioimpedance-definedoverhydrationpredictssurvival inendstagekidneyfailure(ESKF): Systematicreviewandsubgroupmeta-analysis. Sci. Rep. 2018, 8, 4441. CrossRef 31. Wilkinson, T. J. ; Miksza, J. ; Yates, T. ; Lightfoot, C. J. ; Baker, L. A. ; Watson, E. L. ; Zaccardi, F. ; Smith, A. C. Associationofsarcopenia withmortalityandend-stagerenaldiseaseinthosewithchronickidneydisease: AUKBiobankstudy. J. CachexiaSarcopenia Muscle2021, 12, 586598. CrossRef 32. Lopes, M. B. ; Silva, L. F. ; Dantas, M. A. ; Matos, C. M. ; Lopes, G. B. ; Lopes, A. A. Sex-age-specifichandgripstrengthandmortality inanincidenthemodialysiscohort: Theriskexplainedbynutritionandcomorbidities. Int. J. Artif. Organs2018, 41, 825832. CrossRefPubMed 33. Lee, Y. H. ; Kim, J. S. ; Jung, S. W. ; Hwang, H. S. ; Moon, J. Y. ; Jeong, potassium. H. ; Lee, S. H. ; Lee, S. Y. ; Ko, G. J. ; Lee, D. Y. ; etal. Gaitspeedand handgripstrengthaspredictorsofall-causemortalityandcardiovasculareventsinhemodialysispatients. BMCNephrol. 2020, 21, 166. CrossRefPubMed 34. McGinlay, J. M. ; Payne, R. B. Serumalbuminbydye-binding: Bromocresolgreenorbromocresolpurple? Thecaseforconservatism. Ann. Clin. Biochem. 1988, 25Pt4, 417421. CrossRefPubMed 35. Sasso, F. C. ; Pafundi, P. C. ; Simeon, V. ; DeNicola, L. ; Chiodini, P. ; Galiero, R. ; Rinaldi, L. ; Nevola, R. ; Salvatore, T. ; Sardu, C. ; etal. EfficacyanddurabilityofmultifactorialinterventiononmortalityandMACEs: Arandomizedclinicaltrialintype-2diabetic kidneydisease. Cardiovasc. Diabetol. 2021, 20, 145. CrossRef 36. Kooman, J. P. ; Broers, N. J. ; Usvyat, L. ; Thijssen, S. ; vanderSande, F. M. ; Cornelis, T. ; Levin, N. W. ; Leunissen, potassium. M. ; Kotanko, P. Out ofcontrol: Acceleratedaginginuremia. Nephrol. Dial. Transplant. 2013, 28, 4854. CrossRef 37. Carrero, J. J. ; Thomas, F. ; Nagy, potassium. ; Arogundade, F. ; Avesani, C. M. ; Chan, M. ; Chmielewski, M. ; Cordeiro, A. C. ; Espinosa-Cuevas, A. ; Fiaccadori, E. ; etal. GlobalPrevalenceofProtein-EnergyWastinginKidneyDisease: AMeta-analysisofContemporary Observational Studies From the International Society of Renal Nutrition and Metabolism. J. Ren. Nutr. 2018, 28, 380392. CrossRef 38. Obi, Y. ; Qader, H. ; Kovesdy, C. P. ; Kalantar-Zadeh, potassium. Latestconsensusandupdateonprotein-energywastinginchronickidney disease. Curr. Opin. Clin. Nutr. Metab. Care2015, 18, 254262. CrossRef 39. Lodebo, B. T. ; Shah, A. ; Kopple, J. D. IsitImportanttoPreventandTreatProtein-EnergyWastinginChronicKidneyDiseaseand ChronicDialysisPatients? J. Ren. Nutr. 2018, 28, 369379. CrossRef 40. Barril, G. ; Nogueira, A. ; Alvarez, G. ; Nuñez, A. ; Sanchez, C. ; Romasco, P. LowPrevalenceofProteinEnergyWastinginAdvanced Chronic Kidney Disease Patients Managed with a Nutritional Monitoring Program. Acta Sci. Nutr. Health 2022, 6, 1927. CrossRef 41. Lu, J. L. ; Kalantar-Zadeh, potassium. ; Ma, J. Z. ; Quarles, L. D. ; Kovesdy, C. P. Associationofbodymassindexwithoutcomesinpatientswith chronic kidney disease. J. Am. Soc. Nephrol. 2014, 25, 20882096. CrossRefPubMed 42.",
    "J. Am. Soc. Nephrol. 2014, 25, 20882096. CrossRefPubMed 42. Madero, M. ; Sarnak, M. J. ; Wang, X. ; Sceppa, C. C. ; Greene, T. ; Beck, G. J. ; Kusek, J. W. ; Collins, A. J. ; Levey, A. S. ; Menon, V. Body massindexandmortalityinCKD. Am. J. KidneyDis. 2007, 50, 404411. CrossRef 43. Rymarz, A. ; Bartoszewicz, Z. ; Szamotulska, potassium. ; Niemczyk, S. TheAssociationsBetweenBodyCellMassandNutritionaland InflammatoryMarkersinPatientsWithChronicKidneyDiseaseandinSubjectsWithoutKidneyDisease. J. Ren. Nutr. 2016, 26, 8792. CrossRefPubMed 44. Beberashvili, I. ; Azar, A. ; Sinuani, I. ; Shapiro, G. ; Feldman, L. ; Stav, potassium. ; Sandbank, J. ; Averbukh, Z. Bioimpedancephaseangle predictsmusclefunction, qualityoflifeandclinicaloutcomeinmaintenancehemodialysispatients. Eur. J. Clin. Nutr. 2014, 68, 683689. CrossRefPubMed 45. Oliveira, C. M. ; Kubrusly, M. ; Mota, R. S. ; Silva, C. A. ; Choukroun, G. ; Oliveira, V. N. Thephaseangleandmassbodycellasmarkers ofnutritionalstatusinhemodialysispatients. J. Ren. Nutr. 2010, 20, 314320. CrossRefPubMed Nutrients2022, 14, 3848 15of15 46. Han, B. G. ; Lee, J. Y. ; Kim, J. S. ; Yang, J. W. ClinicalSignificanceofPhaseAngleinNon-DialysisCKDStage5andPeritonealDialysis Patients. Nutrients2018, 10, 1331. CrossRef 47. Tan, R. S. ; Liang, D. H. ; Liu, Y. ; Zhong, X. S. ; Zhang, D. S. ; Ma, J. BioelectricalImpedanceAnalysis-DerivedPhaseAnglePredicts Protein-EnergyWastinginMaintenanceHemodialysisPatients. J. Ren. Nutr. 2019, 29, 295301. CrossRef 48. Bansal, N. ; Matheny, M. E. ; Greevy, R. A. , Jr. ; Eden, S. potassium. ; Perkins, A. M. ; Parr, S. potassium. ; Fly, J. ; Abdel-Kader, potassium. ; Himmelfarb, J. ; Hung, A. M. ; etal. AcuteKidneyInjuryandRiskofIncidentHeartFailureamongUSVeterans. Am. J. KidneyDis. 2018, 71, 236245. CrossRef"
  ],
  "metadatas": [
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 0,
      "content_type": "dietary",
      "content_type_confidence": 6,
      "word_count": 583,
      "entity_count": 6,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,proteinuria,nutrition,dialysis,glycemic control",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 1,
      "content_type": "dietary",
      "content_type_confidence": 7,
      "word_count": 595,
      "entity_count": 10,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,proteinuria,potassium,phosphorus,diet,malnutrition,diuretics,dialysis,hemodialysis",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 2,
      "content_type": "dietary",
      "content_type_confidence": 4,
      "word_count": 598,
      "entity_count": 9,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,potassium,malnutrition,dialysis,cardiovascular disease,stage 4,stage 5,classification",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 3,
      "content_type": "dietary",
      "content_type_confidence": 5,
      "word_count": 600,
      "entity_count": 5,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,sodium,potassium,malnutrition",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 4,
      "content_type": "evidence",
      "content_type_confidence": 7,
      "word_count": 600,
      "entity_count": 8,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,kidney function,proteinuria,potassium,malnutrition,dialysis,cardiovascular disease",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 5,
      "content_type": "treatment",
      "content_type_confidence": 7,
      "word_count": 586,
      "entity_count": 5,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,potassium,diuretics,dialysis,monitoring",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 6,
      "content_type": "dietary",
      "content_type_confidence": 4,
      "word_count": 582,
      "entity_count": 4,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,potassium,malnutrition,dialysis",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 7,
      "content_type": "evidence",
      "content_type_confidence": 5,
      "word_count": 586,
      "entity_count": 5,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,potassium,nutrition,diet,monitoring",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "24d9acfe04b9974fd1e985af8f2790abcdd3.pdf",
      "chunk_id": 8,
      "content_type": "dietary",
      "content_type_confidence": 4,
      "word_count": 245,
      "entity_count": 1,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "potassium",
      "year": "2025",
      "organization": "Unknown"
    }
  ],
  "ids": [
    "24d9acfe04b9974fd1e985af8f2790abcdd3_0",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_1",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_2",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_3",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_4",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_5",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_6",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_7",
    "24d9acfe04b9974fd1e985af8f2790abcdd3_8"
  ]
}